Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1923]
News [3529]
Articles [90]
Editorials [5]
Conferences [156]
elearning [19]
Immuno-Oncology: a concept or already a reality?
Prof. Peter Johnson - Cancer Research UK Centre, University of Southampton, UK
Immuno-Oncology: a concept or already a reality? ( Prof. Peter Johnson - Cancer Research UK Centre, University of Southampton, UK )
3 Dec 2013
The immune microenvironment as an anti-cancer therapeutic strategy
Dr Lisa Coussens - Oregon Science & Health University, USA
The immune microenvironment as an anti-cancer therapeutic strategy ( Dr Lisa Coussens - Oregon Science & Health University, USA )
12 Nov 2013
The revolution in personalised healthcare: Towards improved outcomes in...
Dr Frances Shepherd - Princess Margaret Hospital and the University of Toronto...
The revolution in personalised healthcare: Towards improved outcomes in oncology: Conclusion and Summary ( Dr Frances Shepherd - Princess Margaret Hospital and the University of Toronto, Canada )
8 Nov 2013
European Cancer Congress 2013 - News Roundup
Prof Gordon Mcvie - ecancer Managing Editor and the European Institute of...
European Cancer Congress 2013 - News Roundup ( Prof Gordon Mcvie - ecancer Managing Editor and the European Institute of Oncology )
22 Oct 2013
Meeting highlights from the 11th iwNHL 2013: Day 2
Prof John Gribben, Dr Randy Gascoyne, Dr Wyndham Wilson, Dr Myron Czuczman and...
Meeting highlights from the 11th iwNHL 2013: Day 2 ( Prof John Gribben, Dr Randy Gascoyne, Dr Wyndham Wilson, Dr Myron Czuczman and Prof Pfreundschuh )
15 Oct 2013
Survival analysis of a follow-up phase III study of ipilimumab and dacarbazine...
Dr Michele Maio - University Hospital of Siena, Siena, Italy
Survival analysis of a follow-up phase III study of ipilimumab and dacarbazine in metastatic melanoma ( Dr Michele Maio - University Hospital of Siena, Siena, Italy )
4 Oct 2013
Analysis of progression free survival versus overall survival in melanoma
Dr Keith Flaherty - Dana-Farber Cancer Institute, Boston, USA
Analysis of progression free survival versus overall survival in melanoma ( Dr Keith Flaherty - Dana-Farber Cancer Institute, Boston, USA )
3 Oct 2013
New antibody drug, MPDL3280A, in non-small cell lung cancer
Prof Jean-Charles Soria - Institut Gustave Roussy, Paris, France
New antibody drug, MPDL3280A, in non-small cell lung cancer ( Prof Jean-Charles Soria - Institut Gustave Roussy, Paris, France )
3 Oct 2013
Meta-analysis of ipilimumab in metastatic or locally advanced, unresectable...
Prof Dirk Schadendorf - Universitätsklinikum Essen, Essen, Germany
Meta-analysis of ipilimumab in metastatic or locally advanced, unresectable melanoma ( Prof Dirk Schadendorf - Universitätsklinikum Essen, Essen, Germany )
3 Oct 2013
Comment on immunotherapy in lung cancer from the ECC 2013 Scientific Co-Chair
Prof Cora Sternberg - San Camillo and Forlanini Hospitals, Rome, Italy
Comment on immunotherapy in lung cancer from the ECC 2013 Scientific Co-Chair ( Prof Cora Sternberg - San Camillo and Forlanini Hospitals, Rome, Italy )
29 Sep 2013
Results for new antibody drug in non-small cell lung cancer
Prof Jean-Charles Soria - Institut Gustave Roussy, Villejuif, France
Results for new antibody drug in non-small cell lung cancer ( Prof Jean-Charles Soria - Institut Gustave Roussy, Villejuif, France )
29 Sep 2013
Developments with PD1 and immunotherapy in melanoma
Prof Lex Eggermont – Institut Gustave Roussy, Villejuif, France
Developments with PD1 and immunotherapy in melanoma ( Prof Lex Eggermont – Institut Gustave Roussy, Villejuif, France )
19 Jul 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation